Literature DB >> 16378784

Quality of care in for-profit and not-for-profit health plans enrolling Medicare beneficiaries.

Eric C Schneider1, Alan M Zaslavsky, Arnold M Epstein.   

Abstract

BACKGROUND: For-profit health plans now enroll the majority of Medicare beneficiaries who select managed care. Prior research has produced conflicting results about whether for-profit health plans provide lower quality of care.
OBJECTIVE: The objective was to compare the quality of care delivered by for-profit and not-for-profit health plans using Medicare Health Plan Employer Data and Information Set (HEDIS) clinical measures. RESEARCH
DESIGN: This was an observational study comparing HEDIS scores in for-profit and not-for-profit health plans that enrolled Medicare beneficiaries in the United States during 1997. OUTCOME MEASURES: Outcome measures included health plan quality scores on each of 4 clinical services assessed by HEDIS: breast cancer screening, diabetic eye examination, beta-blocker medication after myocardial infarction, and follow-up after hospitalization for mental illness.
RESULTS: The quality of care was lower in for-profit health plans than not-for-profit health plans on all 4 of the HEDIS measures we studied (67.5% vs 74.8% for breast cancer screening, 43.7% vs 57.7% for diabetic eye examination, 63.1% vs 75.2% for beta-blocker medication after myocardial infarction, and 42.1% vs 60.4% for follow-up after hospitalization for mental illness). Adjustment for sociodemographic case-mix and health plan characteristics reduced but did not eliminate the differences, which remained statistically significant for 3 of the 4 measures (not beta-blocker medication after myocardial infarction). Different geographic locations of for-profit and not-for-profit health plans did not explain these differences.
CONCLUSION: By using standardized performance measures applied in a mandatory measurement program, we found that for-profit health plans provide lower quality of care than not-for-profit health plans. Special efforts to monitor and improve the quality of for-profit health plans may be warranted.

Entities:  

Mesh:

Year:  2005        PMID: 16378784     DOI: 10.1016/j.amjmed.2005.05.032

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  12 in total

1.  Receipt of disease-modifying antirheumatic drugs among patients with rheumatoid arthritis in Medicare managed care plans.

Authors:  Gabriela Schmajuk; Amal N Trivedi; Daniel H Solomon; Edward Yelin; Laura Trupin; Eliza F Chakravarty; Jinoos Yazdany
Journal:  JAMA       Date:  2011-02-02       Impact factor: 56.272

2.  Sensitivity of billing claims for cardiovascular disease events among kidney transplant recipients.

Authors:  Krista L Lentine; Mark A Schnitzler; Kevin C Abbott; Kosha Bramesfeld; Paula M Buchanan; Daniel C Brennan
Journal:  Clin J Am Soc Nephrol       Date:  2009-06-18       Impact factor: 8.237

3.  The Growing Executive-Physician Wage Gap in Major US Nonprofit Hospitals and Burden of Nonclinical Workers on the US Healthcare System.

Authors:  Jerry Y Du; Alexander S Rascoe; Randall E Marcus
Journal:  Clin Orthop Relat Res       Date:  2018-10       Impact factor: 4.176

4.  Editor's Spotlight/Take 5: The Growing Executive-Physician Wage Gap and Burden of Nonclinical Workers on the U.S. Healthcare System.

Authors:  Seth S Leopold
Journal:  Clin Orthop Relat Res       Date:  2018-10       Impact factor: 4.176

5.  Association of Follow-Up After an Emergency Department Visit for Mental Illness with Utilization Based Outcomes.

Authors:  Kimberley H Geissler; Michael I Cooper; John E Zeber
Journal:  Adm Policy Ment Health       Date:  2021-01-12

6.  Medicare beneficiaries more likely to receive appropriate ambulatory services in HMOs than in traditional medicare.

Authors:  John Z Ayanian; Bruce E Landon; Alan M Zaslavsky; Robert C Saunders; L Gregory Pawlson; Joseph P Newhouse
Journal:  Health Aff (Millwood)       Date:  2013-07       Impact factor: 6.301

7.  Drug benefit changes under Medicare Advantage Part D: heterogeneous effects on pharmaceutical use and expenditures.

Authors:  Susan L Ettner; W Neil Steers; Norman Turk; Elaine S Quiter; Carol M Mangione
Journal:  J Gen Intern Med       Date:  2011-06-28       Impact factor: 5.128

8.  Entering and exiting the Medicare part D coverage gap: role of comorbidities and demographics.

Authors:  Susan L Ettner; Neil Steers; O Kenrik Duru; Norman Turk; Elaine Quiter; Julie Schmittdiel; Carol M Mangione
Journal:  J Gen Intern Med       Date:  2010-03-09       Impact factor: 5.128

9.  Novel methods for tracking long-term maintenance immunosuppression regimens.

Authors:  Paula M Buchanan; Mark A Schnitzler; Daniel C Brennan; Nino Dzebisashvili; Lisa M Willoughby; David Axelrod; Paolo R Salvalaggio; Kevin C Abbott; Thomas E Burroughs; Krista L Lentine
Journal:  Clin J Am Soc Nephrol       Date:  2007-12-12       Impact factor: 8.237

10.  Better Quality of Care or Healthier Patients? Hospital Utilization by Medicare Advantage and Fee-for-Service Enrollees.

Authors:  Lauren Hersch Nicholas
Journal:  Forum Health Econ Policy       Date:  2013-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.